Literature DB >> 20595633

Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.

Shreeram C Nallar1, Sudhakar Kalakonda, Peng Sun, Yoshihiro Ohmori, Miki Hiroi, Kazumasa Mori, Daniel J Lindner, Dhananjaya V Kalvakolanu.   

Abstract

We have previously isolated GRIM-19, a novel growth suppressor, using a genetic method. GRIM-19 ablates cell growth by inhibiting the transcription factor signal transducer and activator of transcription 3 (STAT3). Up-regulation of STAT3 and growth promotion were observed in a number of human tumors. Although the tumor-suppressive actions of GRIM-19 are known, the structural elements required for its antitumor actions are not understood. Mutational and protein sequence analyses identified a motif in the N terminus of GRIM-19 that exhibited similarity to certain RNA viral proteins. We show that disruption of specific amino acids within this motif cripples the antitumor actions of GRIM-19. These mutants fail to interact with STAT3 efficiently and consequently do not inhibit growth-promoting gene expression. More importantly, we show that a clinically observed mutation in the N terminus of GRIM-19 also weakened its interaction with STAT3 and antitumor action. Together, these studies identify a major role for the N terminus of GRIM-19 in mediating its tumor-suppressive actions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595633      PMCID: PMC2913340          DOI: 10.2353/ajpath.2010.091280

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  75 in total

1.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.

Authors:  E Oda; R Ohki; H Murasawa; J Nemoto; T Shibue; T Yamashita; T Tokino; T Taniguchi; N Tanaka
Journal:  Science       Date:  2000-05-12       Impact factor: 47.728

2.  PUMA, a novel proapoptotic gene, is induced by p53.

Authors:  K Nakano; K H Vousden
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

3.  Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells.

Authors:  M Gross; B Liu; J Tan ; F S French; M Carey; K Shuai
Journal:  Oncogene       Date:  2001-06-28       Impact factor: 9.867

4.  Cooperation between STAT3 and c-jun suppresses Fas transcription.

Authors:  V N Ivanov; A Bhoumik; M Krasilnikov; R Raz; L B Owen-Schaub; D Levy; C M Horvath; Z Ronai
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

5.  Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.

Authors:  G Niu; R Heller; R Catlett-Falcone; D Coppola; M Jaroszeski; W Dalton; R Jove; H Yu
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

6.  Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach.

Authors:  J E Angell; D J Lindner; P S Shapiro; E R Hofmann; D V Kalvakolanu
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

7.  Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells.

Authors:  A Junicho; T Matsuda; T Yamamoto; H Kishi; K Korkmaz; F Saatcioglu; H Fuse; A Muraguchi
Journal:  Biochem Biophys Res Commun       Date:  2000-11-11       Impact factor: 3.575

8.  Regulation of interferon and retinoic acid-induced cell death activation through thioredoxin reductase.

Authors:  X Ma; S Karra; W Guo; D J Lindner; J Hu; J E Angell; E R Hofmann; S P Reddy; D V Kalvakolanu
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

9.  The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.

Authors:  T Iwamoto; T Senga; Y Naito; S Matsuda; Y Miyake; A Yoshimura; M Hamaguchi
Journal:  Oncogene       Date:  2000-09-28       Impact factor: 9.867

10.  Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1.

Authors:  Y Shen; G Devgan; J E Darnell; J F Bromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  4 in total

1.  GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis.

Authors:  Nataly Shulga; John G Pastorino
Journal:  J Cell Sci       Date:  2012-03-05       Impact factor: 5.285

2.  Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Daniel J Lindner; Robert R Lorenz; Eric Lamarre; Xiao Weihua; Dhananjaya V Kalvakolanu
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

Review 3.  GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  Cytokine Growth Factor Rev       Date:  2016-09-15       Impact factor: 7.638

4.  CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition.

Authors:  Mauro Rosales; Arielis Rodríguez-Ulloa; George V Pérez; Vladimir Besada; Thalia Soto; Yassel Ramos; Luis J González; Katharina Zettl; Jacek R Wiśniewski; Ke Yang; Yasser Perera; Silvio E Perea
Journal:  Front Mol Biosci       Date:  2022-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.